Menu
Enrolling by invitation NCT07213622

The Use of Smart Glasses for Saphenous Nerve Adductor Canal Block

No phase Interventional Total Knee Arthroplasty

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Smartglasses.
Who it may be relevant to
Registry conditions: Total Knee Arthroplasty. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The use of smart glasses for saphenous nerve adductor canal blocks compared to standard of care.

Interventions

  • Procedure Smartglasses
    Wearing smart glasses while performing a nerve block

Primary outcome measures

  • Time from needle insertion to complete local anesthetic injection [Time frame: Until the end of the study]
Secondary outcome measures (1)
  • Number of needle adjustments by user, ergonomics, head adjustments [Time frame: until the end of the study]

Eligibility criteria

Inclusion criteria

  • patients 18 years or greater
  • undergoing total knee arthroplasty

Exclusion criteria

  • Patients with local infection at nerve block site
  • BMI >40
  • Patients who are at risk for local anesthesia systemic toxicity due to intraoperative local dose
  • Patients with nerve damage to the femoral or saphenous nerve
  • Documented history of mental or cognitive disabilities in EMR
  • Non-English speaking patient
  • Pregnant Women (self-reported)
  • Prisoners
  • Patients under the age of 18

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • MetroHealth Hospital — Cleveland

Identifiers

NCT: NCT07213622 · STUDY00000465

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗